Versa Vascular is a startup based in the United States, most recent round Series C.
Based in the United States, Versa Vascular is a startup. Its most recent tracked round is Series C.
Versa Vascular develops a minimally invasive medical device for tricuspid valve repair, aiming to treat patients with severe tricuspid regurgitation through a novel transcatheter implant and delivery system.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.